These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24818266)

  • 21. Universal influenza vaccination and live attenuated influenza vaccination of children.
    Glezen WP
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S104-9. PubMed ID: 18820568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [H1N1 influenza vaccines in Tunisia: efficiency and safety].
    Chaabane A; Aouam K; Ben Fredj N; Toumi A; Braham D; A Boughattas N; Chakroun M
    Therapie; 2011; 66(3):281-9. PubMed ID: 21819811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.
    Mahmud S; Hammond G; Elliott L; Hilderman T; Kurbis C; Caetano P; Van Caeseele P; Kettner J; Dawood M
    Vaccine; 2011 Oct; 29(45):7975-81. PubMed ID: 21884747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza and pneumococcal vaccination: how far we have come and how to go farther.
    Wu HM; Abrutyn E
    Infect Control Hosp Epidemiol; 2004 Nov; 25(11):901-3. PubMed ID: 15566020
    [No Abstract]   [Full Text] [Related]  

  • 25. Effectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis.
    Castilla J; Moran J; Martinez-Artola V; Reina G; Martinez-Baz I; Garcia Cenoz M; Alvarez N; Irisarri F; Arriazu M; Elia F; Salcedo E
    Euro Surveill; 2011 Feb; 16(7):. PubMed ID: 21345321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety surveillance of influenza A(H1N1)v monovalent vaccines during the 2009-2010 mass vaccination campaign in France.
    Caillet C; Durrieu G; Jacquet A; Faucher A; Ouaret S; Perrault-Pochat MC; Kreft-Jaïs C; Castot A; Montastruc JL;
    Eur J Clin Pharmacol; 2011 Jun; 67(6):649-51. PubMed ID: 21153631
    [No Abstract]   [Full Text] [Related]  

  • 27. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England.
    Pebody R; Andrews N; Waight P; Malkani R; McCartney C; Ellis J; Miller E
    Vaccine; 2011 Mar; 29(14):2613-8. PubMed ID: 21292008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Four at-risk groups will be first to be vaccinated against swine flu, says chief medical officer.
    Dinsdale P
    BMJ; 2009 Aug; 339():b3363. PubMed ID: 19687089
    [No Abstract]   [Full Text] [Related]  

  • 29. Moderate influenza vaccine effectiveness in Victoria, Australia, 2011.
    Fielding JE; Grant KA; Tran T; Kelly HA
    Euro Surveill; 2012 Mar; 17(11):. PubMed ID: 22449867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden.
    Ortqvist A; Berggren I; Insulander M; de Jong B; Svenungsson B
    Clin Infect Dis; 2011 May; 52(10):1203-11. PubMed ID: 21507917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pandemic influenza A(H1N1)pdm09 improves vaccination routine in subsequent years: a cohort study from 2009 to 2011.
    Tacken MA; Jansen B; Mulder J; Visscher S; Heijnen ML; Campbell SM; Braspenning JC
    Vaccine; 2013 Jan; 31(6):900-5. PubMed ID: 23246546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The 2009 A (H1N1) influenza virus pandemic: A review.
    Girard MP; Tam JS; Assossou OM; Kieny MP
    Vaccine; 2010 Jul; 28(31):4895-902. PubMed ID: 20553769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influenza in Poland in 2002].
    Kuszewski K; Brydak LB; Machała M
    Przegl Epidemiol; 2004; 58(1):45-8. PubMed ID: 15218642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. More choices for avoiding the flu this winter.
    Consum Rep; 2003 Nov; 68(11):47. PubMed ID: 14584505
    [No Abstract]   [Full Text] [Related]  

  • 35. Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign.
    Bone A; Guthmann JP; Nicolau J; Lévy-Bruhl D
    Vaccine; 2010 Nov; 28(51):8157-61. PubMed ID: 20937310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Summary recommendations by the Advisory Committee on Immunization Practices (ACIP) for the use of H1N1 influenza vaccine for the 2009-2010 vaccination season.
    Litchfield SM
    AAOHN J; 2009 Sep; 57(9):354. PubMed ID: 19842610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.
    Castilla J; Morán J; Martínez-Artola V; Fernández-Alonso M; Guevara M; Cenoz MG; Reina G; Alvarez N; Arriazu M; Elía F; Salcedo E; Barricarte A;
    Vaccine; 2011 Aug; 29(35):5919-24. PubMed ID: 21723358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2009-2010 novel influenza A (H1N1) vaccination coverage in the Republic of Korea.
    Lee YK; Kwon Y; Kim DW; Song KM; Cho H; Kim CH; Go UY; Bae GR; Lee JK
    Am J Infect Control; 2012 Jun; 40(5):481-3. PubMed ID: 21868134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Why vaccinate to children against the flu].
    Bernaola E
    Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():15-7. PubMed ID: 20084342
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prophylactic influenza vaccination: what is the situation in Germany?].
    Wutzler P
    Dtsch Med Wochenschr; 2006 Mar; 131(9):453-7. PubMed ID: 16493571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.